Customized to your lifestyle, our medical team ensures you receive the support needed to achieve and maintain your goals
Michos, MD, MHS, FACC, FAHA, FASE, FASPC, professor of medicine and director of Womens Cardiovascular Health at Johns Hopkins School of Medicine, told Healio | Endocrine Today
The product is classified as a health supplement under Singapore's HSA Health Products Act and is not a pharmaceutical drug
Key Takeaways Tirzepatide vs semaglutide comes down to dual agonist vs single agonist: tirzepatide targets both GLP-1 and GIP receptors, while semaglutide targets GLP-1 alone The only head-to-head trial (SURPASS-2) found tirzepatide superior to semaglutide for both blood sugar control and weight loss In separate obesity trials, tirzepatide 15mg achieved 20.9% weight loss at 72 weeks vs semaglutide 2.4mg's 14.9% at 68 weeks Semaglutide has proven cardiovascular benefit (SELECT trial: 20% MACE reduction)
Human data from diabetics suggest longer lifespans compared to non-diabetics, but its unclear if this applies to healthy people
Medical Advisor, Swiss Medica doctor List of References: Myasthenia gravis Diagnosis and treatment Mayo Clinic
